PROPOFOL Injectable Emulsion, 1 g/100 mL (10 mg/mL), packaged in 100 mL glass fliptop…

Class I — High risk. Reasonable probability of serious harm or death.

Recalling firm

Pfizer Inc.

NDC code

0409-4699-54

Origin

NY, United States

Initiated by

Voluntary: Firm initiated

FDA recall number

D-1540-2022

Other Propofol recalls

See all

Class I · High risk Terminated Jul 13, 2022

Propofol Injectable Emulsion, 1 g/100 mL (10 mg/mL), packaged in 100 mL per glass fliptop vial (NDC 0409-4699-54) further…

Reason Presence of particulate matter: particulate identified as a beetle.

Pfizer Inc. NDC 0409-4699-54 D-1301-2022

Class II · Moderate risk Terminated Apr 13, 2022

Diprivan (Propofol) Emulsion, 200 mg per 20 mL (10mg/mL), 20 mL vial, Rx only, MFG: App Pharmaceutical LLC, NDC 63323-269-29

Reason cGMP deviations: Temperature abuse

Mckesson Medical-Surgical Inc. Corporate Office NDC 63323-269-29 D-1116-2022

Class II · Moderate risk Terminated Apr 13, 2022

Diprivan (Propofol) Emulsion, 100 mg/mL, 10mL vial, Rx only, MFG: App Pharmaceutical LLC, NDC 63323-269-10

Reason cGMP deviations: Temperature abuse

Mckesson Medical-Surgical Inc. Corporate Office NDC 63323-269-10 D-1115-2022

Class II · Moderate risk Terminated Apr 13, 2022

Propofol Injectable Emulsion, USP 200 mg per 20 mL (10 mg per mL), twenty-five 20 mL vials, Rx only, MFG: Teva Pharma USA, NDC…

Reason cGMP deviations: Temperature abuse

Mckesson Medical-Surgical Inc. Corporate Office NDC 0591-2136-95 D-1078-2022

Class II · Moderate risk Terminated Apr 13, 2022

Propofol Injectable Emulsion, USP, 200 mg/ 20 mL (10 mg/mL), packaged in a) 50 mL vial, in packs of 20 (NDC 00591-2136-51), b)…

Reason cGMP deviations: Temperature abuse

Mckesson Medical-Surgical Inc. Corporate Office NDC 00591-2136-51 D-1077-2022